T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Verisk Analytics
VRSK
$23.5B
| $980M | 0.12% |
5,663,684
+686,034
| +14% | +$128M |
|
177
State Street
STT
$52.3B
| $977M | 0.12% |
15,850,107
-9,447,376
| -37% | -$668M |
|
178
Loews
L
$23.1B
| $977M | 0.12% |
16,481,416
-2,501,583
| -13% | -$157M |
|
|
FITB
179
Fifth Third Bancorp
FITB
$52.7B
| $971M | 0.12% |
28,907,169
-4,901,783
| -14% | -$184M |
|
|
PXD
180
DELISTED
Pioneer Natural Resource Co.
PXD
| $970M | 0.12% |
4,346,688
+2,569,044
| +145% | +$652M |
|
181
Shopify
SHOP
$198B
| $968M | 0.12% |
31,003,772
-4,044,728
| -12% | -$173M |
|
182
TC Energy
TRP
$65.8B
| $968M | 0.12% |
18,681,210
-1,782,953
| -9% | -$99.5M |
|
183
CF Industries
CF
$17.8B
| $964M | 0.12% |
11,245,664
-1,379,219
| -11% | -$134M |
|
184
SBA Communications
SBAC
$19.6B
| $957M | 0.12% |
2,988,846
+624,389
| +26% | +$210M |
|
185
Conagra Brands
CAG
$7.35B
| $956M | 0.12% |
27,918,907
+2,969,072
| +12% | +$101M |
|
186
RPM International
RPM
$14.5B
| $946M | 0.12% |
12,019,219
+1,709,474
| +17% | +$144M |
|
187
Republic Services
RSG
$66.2B
| $946M | 0.12% |
7,226,762
+1,657,265
| +30% | +$218M |
|
|
SBNY
188
DELISTED
Signature Bank
SBNY
| $940M | 0.12% |
5,244,799
+1,900,674
| +57% | +$426M |
|
189
O'Reilly Automotive
ORLY
$75.1B
| $940M | 0.12% |
22,308,810
-4,981,110
| -18% | -$214M |
|
190
Zimmer Biomet
ZBH
$18.8B
| $938M | 0.12% |
8,929,342
+1,062,625
| +14% | +$126M |
|
191
Monster Beverage
MNST
$91.8B
| $936M | 0.12% |
40,401,036
+30,122,188
| +293% | +$655M |
|
192
American Electric Power
AEP
$68.2B
| $920M | 0.12% |
9,586,395
-1,328,437
| -12% | -$132M |
|
193
CVS Health
CVS
$122B
| $909M | 0.11% |
9,811,248
-384,640
| -4% | -$37.5M |
|
194
Equitable Holdings
EQH
$14.2B
| $903M | 0.11% |
34,650,300
+5,799,164
| +20% | +$168M |
|
195
CME Group
CME
$94.8B
| $899M | 0.11% |
4,390,310
-3,409,694
| -44% | -$723M |
|
196
Repligen
RGEN
$9.34B
| $898M | 0.11% |
5,531,521
+1,755,417
| +46% | +$278M |
|
197
MetLife
MET
$61.7B
| $897M | 0.11% |
14,288,839
-2,761,492
| -16% | -$183M |
|
|
SEE
198
DELISTED
Sealed Air
SEE
| $891M | 0.11% |
15,443,365
-547,024
| -3% | -$34.5M |
|
199
Sanofi
SNY
$105B
| $863M | 0.11% |
17,244,354
+10,684,509
| +163% | +$567M |
|
200
Union Pacific
UNP
$176B
| $854M | 0.11% |
4,004,224
+307,153
| +8% | +$69.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.